Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. - Mitsuboshi S; Hitoshi K; Ominato A; Kinoshita T; Sugimoto Y; Kajiwara-Morita A; Urata M; Sato K; Sakamaki T (European journal of clinical pharmacology, 2025)